MSGUX
Price
$52.90
Change
+$1.22 (+2.36%)
Updated
Dec 3 closing price
Net Assets
4.19B
RGEBX
Price
$85.45
Change
+$0.51 (+0.60%)
Updated
Dec 3 closing price
Net Assets
338.91B
Interact to see
Advertisement

MSGUX vs RGEBX

Header iconMSGUX vs RGEBX Comparison
Open Charts MSGUX vs RGEBXBanner chart's image
Morgan Stanley Inst Growth C
Price$52.90
Change+$1.22 (+2.36%)
VolumeN/A
Net Assets4.19B
American Funds Growth Fund of Amer R2E
Price$85.45
Change+$0.51 (+0.60%)
VolumeN/A
Net Assets338.91B
MSGUX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
MSGUX vs. RGEBX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSGUX is a Buy and RGEBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 339B vs. MSGUX (4.19B). MSGUX (0.00) and RGEBX (0.00) have matching dividends . MSGUX was incepted earlier than RGEBX: MSGUX (11 years) vs RGEBX (11 years). MSGUX (1.62) is less costly to investors than RGEBX (1.09). MSGUX is a more actively managed with annual turnover of: 39.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MSGUX: RGEBX (250) vs MSGUX (1000). MSGUX annual gain was more profitable for investors over the last year : 20.15 vs. RGEBX (7.12). RGEBX return over 5 years is better than : 28.78 vs. MSGUX (-37.81).
MSGUXRGEBXMSGUX / RGEBX
Total Expense Ratio1.621.09149%
Annual Report Gross Expense Ratio1.621.09149%
Fund Existence11 years11 years-
Gain YTD25.80319.611132%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.19B339B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year20.157.12283%
Returns for 3 years98.5060.82162%
Returns for 5 years-37.8128.78-131%
Returns for 10 years27.1087.4431%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSCCX40.910.62
+1.54%
Nuveen Small-Cap Value Opps C
BMSRX15.100.13
+0.87%
MFS Blended Research Mid Cap Eq R1
BCSAX10.230.08
+0.79%
BlackRock Commodity Strategies Inv A
NBRRX28.700.19
+0.67%
Neuberger Berman M/C Intrinsic Val R3
JDEAX49.440.13
+0.26%
JPMorgan US Research Enhanced Equity A